Lv61
1770 积分 2022-05-09 加入
SHP2 inhibition reduces somatotroph tumor growth in a pre-clinical model
1个月前
已关闭
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
A Review of Pancreatic Cancer
1个月前
已完结
Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution
1个月前
已完结
SHP2 inhibition and adjuvant therapy synergistically target KIT‐mutant GISTs via ERK1/2‐regulated GSK3β/cyclin D1 pathway
2个月前
已完结
Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer
2个月前
已完结
Rational combinations of targeted cancer therapies: background, advances and challenges
2个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
2个月前
已完结
Combinatorial strategies to target RAS-driven cancers
2个月前
已完结
Cancer cachexia
3个月前
已完结
皖公网安备34019202002308
